Hikma Pharmaceuticals PLC (HIK.L)
19 Jan 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|58||2014||Chairman of the Board, Chief Executive|
|58||2014||Executive Vice Chairman of the Board; President and Chief Executive Officer of MENA and Emerging Markets|
|2011||Chief Financial Officer|
|2015||President and Chief Executive of - Generics Division|
|2008||President and Chief Executive Officer, USA|
- BRIEF-Hikma gets FDA nod for Sodium Oxybate oral solution
- BRIEF-Hikma announces U.S. deal with Vectura for generic salmeterol development
- BRIEF-Hikma Pharmaceuticals sees FY group revenue to grow by about 35 pct
- BUZZ-Hikma: top Stoxx loser as HSBC cuts TP on DoJ market probe
- BRIEF-Hikma says first-half revenue up 28 pct